Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) has earned an average rating of “Moderate Buy” from the seven research firms that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 1-year price objective […]
Pale Fire Capital SE bought a new stake in IGM Biosciences, Inc. (NASDAQ:IGMS – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 12,601 shares of the company’s stock, valued at approximately $105,000. Several other hedge funds and […]
Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven research firms that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The […]
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report)’s stock price was down 6% during trading on Wednesday . The stock traded as low as $15.06 and last traded at $15.11. Approximately 40,803 shares traded hands during mid-day trading, a decline of 87% from the average daily volume of 310,863 shares. The stock had previously closed […]
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report)’s stock price traded down 6% during mid-day trading on Wednesday . The stock traded as low as $15.06 and last traded at $15.11. 40,803 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 310,863 shares. The stock had previously closed […]